News Digest #211 – SynBioBeta Q1 Breaks $650m, Trump Appoints Elizabeth Holmes to FDA.

Hi all,

The synthetic biology industry raised over $650 million in Q1, more than double Q1 2017, setting the pace for another record-breaking year. The infographic below shows the big movers, and we’ll go deeper into all the companies in next week’s digest. You can hear Wild Earth, Opentrons, Prokarium, Twist Bioscience and many more speaking at SynBioBeta in October -- register by Friday April 6th before the early bird discount ends.

A new report from Cambridge Consultants (one of SynBioBeta’s sponsors) says that for synthetic biology to become a commercially-focused technology in the next five years, it will need to achieve predictability, a competitive supply-chain, and accessibility.

Regards,John

Trump taps Elizabeth Holmes to lead FDA

SGI-DNA launches automated gene libraries for drug discovery

Can bacteria in clothing really make an athlete faster?

Who's Hiring?

Research Fellow in Open Synthetic Biology: CRI, ParisSynthetic biologist/Protein engineer: XENO Cell Innovations, Pilsen, Czech RepublicProduct Manager, Cells: Synthego, California